PRP showdown: which injection eases hip pain best?
NCT ID NCT05497349
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests two versions of platelet-rich plasma (PRP) injections—one with white blood cells and one without—to see which better reduces pain and stiffness in people with hip osteoarthritis. About 230 adults with mild to moderate hip OA will receive ultrasound-guided injections and be followed for a year. The goal is to find the most effective way to ease symptoms and improve daily function.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIP OSTEOARTHRITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Istituto Ortopedico Rizzoli
RECRUITINGBologna, 40136, Italy
Contact Phone: •••-•••-••••
Contact Phone: •••-•••-•••• Email: •••••@•••••